Anthem, Inc. Completes Acquisition of Aspire Health

Anthem, Inc. (NYSE:ANTM) announced today the completion of its
acquisition of Aspire Health, the nation’s largest provider of
non-hospice, community-based palliative care for people facing a serious

“Anthem is focused on leading the industry by offering innovative,
integrated clinical care models that help to transform how we deliver
care, enhance quality and improve outcomes,” said Gail K. Boudreaux,
President and CEO, Anthem. “With the addition of Aspire, we are able to
expand our capabilities and serve a broader set of consumers in the home
and other settings outside of the hospital, while further deepening our
relationships within the healthcare community. The addition of Aspire to
Anthem’s other clinical care services, such as CareMore and AIM, will
provide tremendous benefit to our consumers, customers, health plan and
provider partners as well as future growth opportunities for our

Aspire Health offers specialized medical care focused on addressing a
patient’s specific symptoms, pain, and stress; and improving quality of
life for both patients and their families. Working together with a
patient’s medical team, Aspire’s clinicians develop an integrated care
plan to help manage symptoms such as pain, shortness of breath, fatigue,
nausea, loss of appetite, difficulty sleeping and depression. The
company also offers 24/7 support to patients, including nurse
practitioner home visits.

Aspire Health will operate as a wholly-owned subsidiary of Anthem, and
its associates will join Anthem’s Diversified Business Group. Financial
terms of the transaction were not disclosed, and the transaction is
expected to be neutral to earnings in 2018 and accretive to earnings in

About Anthem, Inc.

Anthem is working to transform health care with trusted and caring
solutions. Our health plan companies deliver quality products and
services that give their members access to the care they need. With over
74 million people served by its affiliated companies, including nearly
40 million within its family of health plans, Anthem is one of the
nation’s leading health benefits companies. For more information about
Anthem’s family of companies, please visit www.antheminc.com/companies.

Forward-Looking Statements

This document contains “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements reflect our views about future events and
financial performance and are generally not historical facts. Words such
as “expect,” “feel,” “believe,” “will,” “may,” “should,” “anticipate,”
“intend,” “estimate,” “project,” “forecast,” “plan” and similar
expressions are intended to identify forward-looking statements. These
statements include, but are not limited to: financial projections and
estimates and their underlying assumptions; statements regarding plans,
objectives and expectations with respect to future operations, products
and services; and statements regarding future performance. Such
statements are subject to certain risks and uncertainties, many of which
are difficult to predict and generally beyond our control, that could
cause actual results to differ materially from those expressed in, or
implied or projected by, the forward-looking statements. You are
cautioned not to place undue reliance on these forward-looking
statements that speak only as of the date hereof. You are also urged to
carefully review and consider the various risks and other disclosures
discussed in our reports filed with the U.S. Securities and Exchange
Commission from time to time, which attempt to advise interested parties
of the factors that affect our business. Except to the extent otherwise
required by federal securities laws, we do not undertake any obligation
to republish revised forward-looking statements to reflect events or
circumstances after the date hereof. These risks and uncertainties
include, but are not limited to: the impact of federal and state
regulation, including ongoing changes in the Patient Protection and
Affordable Care Act and the Health Care and Education Reconciliation Act
of 2010, as amended, or collectively the ACA; trends in healthcare costs
and utilization rates; our ability to contract with providers on
cost-effective and competitive terms; our ability to secure sufficient
premium rates including regulatory approval for and implementation of
such rates; reduced enrollment; risks and uncertainties regarding
Medicare and Medicaid programs, including those related to
non-compliance with the complex regulations imposed thereon, our ability
to maintain and achieve improvement in Centers for Medicare and Medicaid
Services, or CMS, Star ratings and other quality scores and funding
risks with respect to revenue received from participation therein;
competitive pressures, including competitor pricing, which could affect
our ability to maintain or increase our market share; a negative change
in our healthcare product mix; our ability to adapt to changes in the
industry and develop and implement strategic growth opportunities; costs
and other liabilities associated with litigation, government
investigations, audits or reviews; the ultimate outcome of litigation
between Cigna Corporation, or Cigna, and us related to the merger
agreement between the parties, including our claim for damages against
Cigna, Cigna’s claim for payment of a termination fee and other damages
against us, and the potential for such litigation to cause us to incur
substantial costs, materially distract management and negatively impact
our reputation and financial positions; medical malpractice or
professional liability claims or other risks related to healthcare
services provided by our subsidiaries; possible restrictions in the
payment of dividends by our subsidiaries and increases in required
minimum levels of capital; the potential negative effect from our
substantial amount of outstanding indebtedness; a downgrade in our
financial strength ratings; the effects of any negative publicity
related to the health benefits industry in general or us in particular;
unauthorized disclosure of member or employee sensitive or confidential
information, including the impact and outcome of any investigations,
inquiries, claims and litigation related thereto; failure to effectively
maintain and modernize our information systems; non-compliance by any
party with the Express Scripts, Inc. pharmacy benefit management
services agreement, which could result in financial penalties, our
inability to meet customer demands, and sanctions imposed by
governmental entities, including CMS; state guaranty fund assessments
for insolvent insurers; events that may negatively affect our licenses
with the Blue Cross and Blue Shield Association; regional concentrations
of our business and future public health epidemics and catastrophes;
general risks associated with mergers, acquisitions and strategic
alliances; our ability to repurchase shares of our common stock and pay
dividends on our common stock due to the adequacy of our cash flow and
earnings and other considerations; possible impairment of the value of
our intangible assets if future results do not adequately support
goodwill and other intangible assets; changes in economic and market
conditions, as well as regulations that may negatively affect our
liquidity and investment portfolios; changes in U.S. tax laws; intense
competition to attract and retain employees; various laws and provisions
in our governing documents that may prevent or discourage takeovers and
business combinations; and general economic downturns.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180618005754/en/